382 related articles for article (PubMed ID: 28412855)
1. Decreased TLR4 expression on monocytes may cause regulatory T cells abnormality in patients with primary immune thrombocytopenia.
Hao Y; Li H; Li Y; Lyu M; Zhang D; Fu R; Guan Y; Wang S; Sun B; Dou X; Yang R
Autoimmunity; 2017 Aug; 50(5):283-292. PubMed ID: 28412855
[TBL] [Abstract][Full Text] [Related]
2. Involvement of levels of Toll like receptor-4 in monocytes, CD4+ T-lymphocyte subsets, and cytokines in patients with immune thrombocytopenic purpura.
Liu H; Ouyang X; Li Y; Zeng H; Wang X; Xie S; Nie D; Xiao J; Wei J; Wu Y; Yin S; Ma L
Thromb Res; 2013 Aug; 132(2):196-201. PubMed ID: 23830211
[TBL] [Abstract][Full Text] [Related]
3. Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imbalance via T-helper 17-associated signaling pathway in immune thrombocytopenia.
Hu Y; Wang X; Yu S; Hou Y; Ma D; Hou M
Expert Opin Ther Targets; 2015 Jun; 19(6):723-32. PubMed ID: 25976230
[TBL] [Abstract][Full Text] [Related]
4. The aberrant expression of microRNAs and correlations with T cell subsets in patients with immune thrombocytopenia.
Liu L; Hua M; Liu C; He N; Li Z; Ma D
Oncotarget; 2016 Nov; 7(47):76453-76463. PubMed ID: 27802180
[TBL] [Abstract][Full Text] [Related]
5. Correction of abnormal T cell subsets by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura.
Li J; Wang Z; Hu S; Zhao X; Cao L
Immunol Lett; 2013; 154(1-2):42-8. PubMed ID: 23994430
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 35 may contribute to the loss of immunological self-tolerance in patients with primary immune thrombocytopenia.
Sun T; Zhang D; Yang Y; Zhang X; Lv C; Fu R; Lv M; Liu W; Chen Y; Liu W; Huang Y; Xue F; Liu X; Zhang L; Li H; Yang R
Br J Haematol; 2015 Apr; 169(2):278-85. PubMed ID: 25640666
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17-producing CD4+ T lymphocytes are increased in patients with primary immune thrombocytopenia.
Zhou L; Xu F; Chang C; Tao Y; Song L; Li X
Blood Coagul Fibrinolysis; 2016 Apr; 27(3):301-7. PubMed ID: 26484642
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of microRNA in CD4
Hua M; Li J; Wang C; Shao L; Hou M; Peng J; Feng Q
Thromb Res; 2019 May; 177():70-78. PubMed ID: 30856381
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Th1/Th2 and Th17/Treg by pDC/mDC imbalance in primary immune thrombocytopenia.
Li Q; Liu Y; Wang X; Sun M; Wang L; Wang X; Liu Y; Fan W; Zhang K; Sui X; Guo X
Exp Biol Med (Maywood); 2021 Aug; 246(15):1688-1697. PubMed ID: 33938255
[TBL] [Abstract][Full Text] [Related]
10. CD16+ monocytes control T-cell subset development in immune thrombocytopenia.
Zhong H; Bao W; Li X; Miller A; Seery C; Haq N; Bussel J; Yazdanbakhsh K
Blood; 2012 Oct; 120(16):3326-35. PubMed ID: 22915651
[TBL] [Abstract][Full Text] [Related]
11. Transcription Factor IRF4 Dysfunction Affects the Immunosuppressive Function of Treg Cells in Patients with Primary Immune Thrombocytopenia.
Tang M; Cheng L; Li F; Wu B; Chen P; Zhan Y; Hua F; Min Z; Ke Y; Liu C; Yuan L; Sun L; Chen H; Ji L; Cheng Y
Biomed Res Int; 2019; 2019():1050285. PubMed ID: 31380412
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Th17/Treg cells and Th cytokines in an improved immune thrombocytopenia mouse model.
Zhang G; Zhang P; Liu H; Liu X; Xie S; Wang X; Wu Y; Chang J; Ma L
Hematology; 2017 Sep; 22(8):493-500. PubMed ID: 28300523
[TBL] [Abstract][Full Text] [Related]
13. The potential therapeutic benefit of resveratrol on Th17/Treg imbalance in immune thrombocytopenic purpura.
Guo NH; Fu X; Zi FM; Song Y; Wang S; Cheng J
Int Immunopharmacol; 2019 Aug; 73():181-192. PubMed ID: 31102993
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of Notch signaling reverses the Th17/Treg imbalance in cells from patients with immune thrombocytopenia.
Yu S; Liu C; Li L; Tian T; Wang M; Hu Y; Yuan C; Zhang L; Ji C; Ma D
Lab Invest; 2015 Feb; 95(2):157-67. PubMed ID: 25485537
[TBL] [Abstract][Full Text] [Related]
15. PD-1/PD-L1 pathway activation restores the imbalance of Th1/Th2 and treg/Th17 cells subtypes in immune thrombocytopenic purpura patients.
Wu D; Liu Y; Pang N; Sun M; Wang X; Haridia Y; Zhao F; Qin Y; Fan W; Guo X; Ding J
Medicine (Baltimore); 2019 Oct; 98(43):e17608. PubMed ID: 31651870
[TBL] [Abstract][Full Text] [Related]
16. Insufficient secretion of IL-10 by Tregs compromised its control on over-activated CD4+ T effector cells in newly diagnosed adult immune thrombocytopenia patients.
Li F; Ji L; Wang W; Hua F; Zhan Y; Zou S; Yuan L; Ke Y; Min Z; Song D; Sun L; Chen H; Cheng Y
Immunol Res; 2015 Mar; 61(3):269-80. PubMed ID: 25550089
[TBL] [Abstract][Full Text] [Related]
17. Decreased immunosuppressive actions of 1α, 25-dihydroxyvitamin D
Liu W; Li H; Hao Y; Li Y; Lv M; Xue F; Liu X; Zhang L; Yang R
Mol Immunol; 2016 Oct; 78():89-97. PubMed ID: 27614264
[TBL] [Abstract][Full Text] [Related]
18. [A study of immunocyte subsets and serum cytokine profiles before and after immunal suppression treatment in patients with immune thrombocytopenia].
Li W; Wang X; Li J; Liu M; Feng J
Zhonghua Nei Ke Za Zhi; 2016 Feb; 55(2):111-5. PubMed ID: 26875579
[TBL] [Abstract][Full Text] [Related]
19. An increased expression profile of Th9/IL-9 correlated with Th17/IL-17 in patients with immune thrombocytopenia.
Qiao J; Li X; Wu Y; Wu X; Zhu F; Liu N; Qi K; Cheng H; Li D; Sun H; Zeng L; Xu K
Platelets; 2017 May; 28(3):287-294. PubMed ID: 27662073
[TBL] [Abstract][Full Text] [Related]
20. Effect of ADSCs on Th17/Treg and T-bet/GATA-3 in model mice with primary immune thrombocytopenia.
Dong H; Ren Z; Shao W; Duan G; Du A; Du B
Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):150-154. PubMed ID: 38814224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
